ALS-Answers

Ask 100+ experts questions

Veröffentlicht von: MedAnswers

Beschreibung

MedAnswers helps those with personal health related questions get the answers they need from a curated, trusted network of board-certified professionals and patient advocates. We partnered with Unite, a leading health technology company accelerating research for diseases without cures, to bring ALS-Answers to the app store.

For those who are living with Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, or people suspecting they have ALS, we assembled a network of professionals to answer your anonymous, personal questions:
+ Neurologists
+ ALS Nurses
+ Geneticists
+ Genetic counselors
+ Psychologists
+ Patient Advocates
And more . . .

Users can:
+ Read and favorite other users' anonymous questions and the answers provided
+ Thank the professional who provided a helpful answer
+ Follow your favorite professionals
+ Complete anonymous, health surveys that enable more accurate answers
+ Browse helpful programs related to the diagnosis and treatment of ALS
+ Learn about clinical trials they may qualify for
+ Ask anything at any time, for free!

We provide:
+ A predictive content feed based on your category selections and activity
+ Access to our network of professionals for free - we add new professionals every week!
+ Consensus on the answers by our network (where else can you have multiple professionals weigh in on your question?!)
+ HIPAA-compliant platform so your data and activity are kept in the strictest confidence.
+ The ability for you to request a consult with a clinical trial concierge

Coming Soon:
+ MedAnswers App with multiple conditions and disease categories
+ More clinical trials related to your treatment goals
+ Recommended products and services for your health conditions
CONNECT WITH US AND OUR ALS-ANSWERS PARTNER

MedAnswers
Web: https://www.medanswers.com/
LinkedIn: https://www.linkedin.com/company/MedAnswers

Unite
Web: https://www.unitegenomics.com
LinkedIn: https://www.linkedin.com/company/unite-genomics-inc/
Facebook: https://www.facebook.com/UniteGenomics/


Twitter: https://mobile.twitter.com/unitegenomics
Instagram: https://www.instagram.com/unitegenomics/?hl=en
If you have technical questions, contact [email protected]
For full Privacy Policy and our Terms of Service:
https://www.medanswers.com/privacy
https://www.medanswers.com/patients-terms
Ausblenden Mehr anzeigen...

Screenshots

ALS-Answers Häufige Fragen

  • Ist ALS-Answers kostenlos?

    Ja, ALS-Answers ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist ALS-Answers seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet ALS-Answers?

    ALS-Answers ist kostenlos.

  • Wie hoch ist der Umsatz von ALS-Answers?

    Um geschätzte Einnahmen der ALS-Answers-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Nigeria noch nicht bewertet.
Bewertungsverlauf

ALS-Answers Bewertungen

Keine Bewertungen in Nigeria
Die App hat noch keine Bewertungen in Nigeria.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

ALS-Answers Installationen

Letzte 30 Tage

ALS-Answers Umsatz

Letzte 30 Tage

ALS-Answers Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von ALS-Answers mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.